Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [3]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN394023 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-NK3 Homeobox 1 (NKX3-1) (AA 100-210) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Epitope
- AA 100-210
- Isotype
- IgG
- Antibody clone number
- 1C7
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
NKX3.1 as a marker of prostatic origin in metastatic tumors.
NKX3.1 activates cellular response to DNA damage.
Kunderfranco P, Mello-Grand M, Cangemi R, Pellini S, Mensah A, Albertini V, Malek A, Chiorino G, Catapano CV, Carbone GM
PloS one 2010 May 10;5(5):e10547
PloS one 2010 May 10;5(5):e10547
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA, Preece DM, Bentel JM
The Biochemical journal 2010 Jan 15;425(3):575-83
The Biochemical journal 2010 Jan 15;425(3):575-83
Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
Kim ST, Cheng Y, Hsu FC, Jin T, Kader AK, Zheng SL, Isaacs WB, Xu J, Sun J
The Prostate 2010 Dec 1;70(16):1729-38
The Prostate 2010 Dec 1;70(16):1729-38
NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM
The American journal of surgical pathology 2010 Aug;34(8):1097-105
The American journal of surgical pathology 2010 Aug;34(8):1097-105
NKX3.1 activates cellular response to DNA damage.
Bowen C, Gelmann EP
Cancer research 2010 Apr 15;70(8):3089-97
Cancer research 2010 Apr 15;70(8):3089-97
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA